Clinical Laboratory Services Markets: Market Forecast, Competitive Landscape, Consolidation and Strategy, 2027-2031

Clinical laboratory testing guides diagnosis, treatment and prevention across every part of healthcare, from routine chemistry and blood counts to genetic and genomic testing. This report estimates the global market for clinical laboratory services, valued at the price paid for testing, at $210.0 billion in 2026, growing 6.3% a year to $285.0 billion in 2031 and adding $75.0 billion of new annual spending. 69 companies are profiled.

Genetic & Genomic Testing grows fastest at 14.7% a year, and together with Molecular Diagnostics (10.1% a year) takes 36% of new spending. Clinical Chemistry & Immunoassay remains the largest test type at $85,050 million in 2026, but its share falls from 40.5% to 36.5%. Independent & Reference Labs take 43% of the growth as health systems sell or share their outreach businesses, and Oncology is the fastest-growing clinical area at 9.2% a year. Public Insurance pays for 58.0% of testing by 2031, and China is the fastest-growing major country at 8.8% a year.

2026 reshaped the industry. Labcorp agreed to buy BioReference businesses from OPKO for up to $872 million, Quest and Corewell Health formed a joint laboratory in Michigan, Congress delayed PAMA payment cuts to 2027 and CMS then proposed new rates averaging about 16% lower, CMS and CDC began a review of CLIA, and the FDA cleared new Alzheimer's blood tests.

"Clinical Laboratory Services Markets" provides data that analysts and planners can use: test menu and volume trends, hospital laboratories and outreach, technology, automation and AI, business models and consumer testing, regulation and reimbursement, pricing, costs and workforce, China and emerging markets, a deal database, laboratory operations, 10 market-moving developments, SWOT and strategic recommendations.

The report includes detailed breakouts for 14 countries and regions. A detailed breakout for any country in the world is available to purchasers of the report.

Product Code: CLIN 1026

List of Tables

List of Figures

1. Executive Summary

1.1 Situation Analysis
1.2 Market Snapshot
1.3 Key Findings
1.4 Investment & Strategic Thesis

2. Research Methodology & Scope

2.1 Market Definition
2.2 Segments
2.3 Forecast Approach
2.4 Comparison with Other Estimates
2.5 Data Sources
2.6 Limitations
2.7 Authors

3. Introduction to Clinical Laboratory Services

3.1 What Clinical Laboratories Do
3.2 The Test Menu
3.3 From Order to Result: The Patient Journey
3.4 Structure of the Industry by Laboratory Type
3.5 The Players
3.6 How Laboratories Are Paid
3.7 Industry Structure by Country
3.8 The Changing Role of the Clinical Laboratory

4. The Global Market for Clinical Laboratory Services

4.1 Global Market Overview by Country
4.2 Global Market by Test Type – Overview
4.3 Global Market by Laboratory Type – Overview
4.4 Global Market by Cost Component – Overview
4.5 Global Market by Payer – Overview
4.6 Global Market by Clinical Area – Overview

5. Test Menu, Volume & Utilisation Trends

5.1 Overview
5.2 Routine and Esoteric Testing
5.3 The Most Commonly Ordered Tests
5.4 Volume and Utilisation
5.5 New Test Categories
5.6 Test Menu Outlook, 2027–2031

6. Hospital Laboratories & Outreach

6.1 The Hospital Laboratory's Place in the System
6.2 Inpatient, Outpatient and Outreach
6.3 Why Health Systems Sell Outreach
6.4 Outreach and Hospital Laboratory Deals, 2023–2026
6.5 Deal Structures
6.6 Health-System Strategies
6.7 Hospital Laboratories Outside the U.S.
6.8 Outlook for Hospital Laboratories, 2027–2031

7. Technology, Automation & AI

7.1 Overview
7.2 Total Laboratory Automation
7.3 Decentralisation and Point of Care in the Laboratory Network
7.4 Mass Spectrometry
7.5 Molecular and Sequencing Platforms
7.6 Digital Pathology
7.7 AI in Result Interpretation and Laboratory Operations
7.8 LIS, Connectivity and Epic
7.9 Collection Technology
7.10 Technology Outlook, 2027–2031

8. Business Models & Consumer Testing

8.1 Overview
8.2 The Independent Laboratory Model
8.3 Patient Service Centres and Access
8.4 Specialty and Single-Test Laboratories
8.5 Consumer-Initiated Testing
8.6 Employer, Payer and Government Contracts
8.7 Pharma Central Laboratories
8.8 Other Models
8.9 Outlook for Business Models, 2027–2031

9. Regulatory & Reimbursement Landscape

9.1 Overview: Rules That Set the Price
9.2 United States: Medicare Payment
9.3 United States: Coverage Management and Prior Authorisation
9.4 United States: Laboratory Regulation
9.5 Europe
9.6 Japan
9.7 China
9.8 Other Markets
9.9 Implications for the Forecast

10. Pricing, Costs & Workforce

10.1 Overview
10.2 Price Trends
10.3 Cost Components
10.4 Workforce
10.5 Productivity
10.6 Outlook for Prices, Costs and Workforce

11. China and Emerging Markets Laboratory Ecosystem

11.1 Overview
11.2 China
11.3 India
11.4 Brazil and Latin America
11.5 Middle East and Africa
11.6 Southeast Asia
11.7 Implications for Global Companies

12. Deal-Making & M&A Analysis

12.1 Deal Database
12.2 Deal Themes
12.3 Valuation Trends
12.4 Outlook for Deal-Making

13. Recent Developments

13.1 Recent Developments – Importance and How to Use This Section
13.2 Labcorp Agrees to Acquire Select BioReference Health Assets from OPKO
13.3 Congress Delays PAMA Cuts and Updates the Data Period
13.4 CMS and CDC Seek Input on Modernising CLIA
13.5 Quest and Corewell Health Launch Diagnostic Lab of Michigan
13.6 Quest Reports Strong Second Quarter and Raises 2026 Guidance
13.7 Labcorp Reports Second Quarter Results and Raises 2026 Guidance
13.8 FDA Clears Roche Elecsys pTau217 and C2N PrecivityAD2 Alzheimer's Blood Tests
13.9 Abbott Completes Acquisition of Exact Sciences
13.10 Medicare Multi-Cancer Early Detection Screening Coverage Act Becomes Law
13.11 FDA Rescinds Its Laboratory-Developed Test Rule

14. Laboratory Operations & Supply Chain

14.1 Overview
14.2 Specimen Logistics and Couriers
14.3 Pre-Analytics: Where Most Errors Occur
14.4 Turnaround Time
14.5 Quality and Accreditation
14.6 Cybersecurity and Resilience
14.7 Reagent and Instrument Supply
14.8 Staffing Models
14.9 Sustainability
14.10 Implications for Laboratories and Suppliers

15. Competitive Landscape

15.1 Market Structure
15.2 Industry Structure: Players in a Dynamic Market
15.3 The U.S. National Laboratories
15.4 International Laboratory Groups
15.5 Hospital and Academic Reference Laboratories
15.6 Specialty Laboratories
15.7 Consumer Platforms
15.8 Leading Companies by Segment
15.9 Estimated Competitive Tiers
15.10 Suppliers to the Laboratory
15.11 Laboratory IT and Services
15.12 Outlook

16. SWOT, Porter's Five Forces & Investment Risk Analysis

16.1 Factors Driving Growth
16.2 Factors Limiting Growth
16.3 SWOT Analysis
16.4 Porter's Five Forces
16.5 Key Investment Risks
16.6 Investment Risk Matrix

17. Strategic Recommendations

17.1 Guidance for Executives, Marketing, Sales and Business Development
17.2 White-Space Opportunities
17.3 Partnering Strategy Guidance
17.4 Recommendations by Company Type
17.5 Guide for Management Consultants and Investment Advisors

18. Market Forecast by Test Type, 2026–2031

18.1 Clinical Chemistry & Immunoassay
18.2 Haematology & Coagulation
18.3 Microbiology & Infectious Disease
18.4 Molecular Diagnostics
18.5 Anatomic Pathology & Cytology
18.6 Genetic & Genomic Testing
18.7 Esoteric & Other Specialty

19. Market Forecast by Laboratory Type, 2026–2031

19.1 Hospital Inpatient
19.2 Hospital Outpatient
19.3 Independent & Reference Labs
19.4 Physician Office Labs
19.5 Public Health & Other

20. Market Forecast by Cost Component, 2026–2031

20.1 Instruments
20.2 Reagents & Consumables
20.3 Labour
20.4 Overhead & Other

21. Market Forecast by Payer, 2026–2031

21.1 Public Insurance
21.2 Private Insurance
21.3 Out-of-Pocket & Other

22. Market Forecast by Clinical Area, 2026–2031

22.1 Chronic & Metabolic Disease
22.2 Infectious Disease
22.3 Oncology
22.4 Women's & Reproductive Health
22.5 Wellness, Preventive & Other

23. Company Profiles

23.1 Abbott Diagnostics (core laboratory)
23.2 Abbott (Exact Sciences)
23.3 Acibadem Labmed
23.4 Adicon Holdings
23.5 Aegis Sciences Corporation
23.6 Ambry Genetics (Tempus)
23.7 ARUP Laboratories
23.8 Australian Clinical Labs
23.9 Beckman Coulter (Danaher)
23.10 BGI Genomics
23.11 Biogroup
23.12 bioMerieux
23.13 Bio-Rad Laboratories
23.14 BioReference Health (OPKO Health)
23.15 BML Inc.
23.16 C2N Diagnostics
23.17 Caris Life Sciences
23.18 Castle Biosciences
23.19 Cepheid (Danaher)
23.20 Cerba HealthCare
23.21 Clinisys
23.22 DASA (Diagnosticos da America)
23.23 Dian Diagnostics
23.24 Dr Lal PathLabs
23.25 Eurofins Scientific
23.26 Everlywell (Everly Health)
23.27 Exagen
23.28 Fleury Group
23.29 Foundation Medicine (Roche)
23.30 Fujirebio
23.31 Fulgent Genetics
23.32 Function Health
23.33 GeneDx
23.34 Guardant Health
23.35 Healius
23.36 Hologic
23.37 H.U. Group
23.38 Inpeco
23.39 KingMed Diagnostics
23.40 Labcorp
23.41 LifeLabs (Quest)
23.42 Mayo Clinic Laboratories
23.43 Medicover
23.44 Metropolis Healthcare
23.45 Mindray
23.46 Myriad Genetics
23.47 Natera
23.48 NeoGenomics
23.49 PathAI
23.50 PathGroup
23.51 PureLab (PureHealth)
23.52 Quest Diagnostics
23.53 QuidelOrtho
23.54 Roche Diagnostics
23.55 Siemens Healthineers
23.56 Snibe
23.57 Sonic Healthcare
23.58 Sonora Quest Laboratories
23.59 Synlab
23.60 Sysmex (Sysmex Inostics)
23.61 Tempus AI
23.62 Thermo Fisher Scientific
23.63 Thyrocare Technologies
23.64 TriCore Reference Laboratories
23.65 Unilabs
23.66 Veracyte
23.67 Waters Corporation
23.68 Werfen
23.69 XiFin

24. Appendix

24.1 Abbreviations
24.2 Developments Archive
24.3 Report Limitations Restated

Product Code: CLIN 1026

List of Tables

Table 1 Clinical Laboratory Services Market Summary, 2026 and 2031
Table 2 Clinical Laboratory Services Market by Country, 2026 and 2031
Table 3 Leading Clinical Laboratory Groups, 2026
Table 4 Scope of the Clinical Laboratory Services Market
Table 5 Forecast Segments
Table 6 Clinical Laboratory Departments and Test Types
Table 7 Players in the Clinical Laboratory Services Industry
Table 8 Factors Affecting Local Clinical Testing Demand
Table 9 Global Market by Country
Table 10 Global Market by Test Type
Table 11 Global Market by Laboratory Type
Table 12 Global Market by Cost Component
Table 13 Global Market by Payer
Table 14 Global Market by Clinical Area
Table 15 Routine and Esoteric Testing Compared
Table 16 Commonly Ordered Clinical Laboratory Tests
Table 17 New and Fast-Growing Test Categories, October 2026
Table 18 Hospital Laboratory Activities and Outsourcing
Table 19 Selected Outreach and Hospital Laboratory Transactions, 2023–2026
Table 20 Strategic Options for Health-System Laboratories
Table 21 Key Clinical Laboratory Technology Trends
Table 22 Selected Laboratory Automation Platforms
Table 23 AI Applications in the Clinical Laboratory
Table 24 Clinical Laboratory Business Models
Table 25 Selected Consumer and Wellness Testing Platforms
Table 26 PAMA and the Clinical Laboratory Fee Schedule
Table 27 Laboratory Price Setting in Selected Markets
Table 28 Indicative Price Positions by Test Type
Table 29 Cost Components of Laboratory Testing
Table 30 Leading Independent Laboratory Groups in China
Table 31 Leading Laboratory Groups in India
Table 32 Selected Deals in Clinical Laboratory Services, 2023–2026
Table 33 Quest Diagnostics and Labcorp Compared
Table 34 Leading Companies by Segment
Table 35 Estimated Competitive Tiers in Clinical Laboratory Services
Table 36 Leading Suppliers to Clinical Laboratories
Table 37 Factors Driving Growth
Table 38 Factors Limiting Growth
Table 39 Investment Risk Matrix
Table 40 Recommendations by Company Type
Table 41 Clinical Chemistry & Immunoassay by Country
Table 42 Haematology & Coagulation by Country
Table 43 Microbiology & Infectious Disease by Country
Table 44 Molecular Diagnostics by Country
Table 45 Anatomic Pathology & Cytology by Country
Table 46 Genetic & Genomic Testing by Country
Table 47 Esoteric & Other Specialty by Country
Table 48 Hospital Inpatient by Country
Table 49 Hospital Outpatient by Country
Table 50 Independent & Reference Labs by Country
Table 51 Physician Office Labs by Country
Table 52 Public Health & Other by Country
Table 53 Instruments by Country
Table 54 Reagents & Consumables by Country
Table 55 Labour by Country
Table 56 Overhead & Other by Country
Table 57 Public Insurance by Country
Table 58 Private Insurance by Country
Table 59 Out-of-Pocket & Other by Country
Table 60 Chronic & Metabolic Disease by Country
Table 61 Infectious Disease by Country
Table 62 Oncology by Country
Table 63 Women's & Reproductive Health by Country
Table 64 Wellness, Preventive & Other by Country

List of Figures

Figure 1 Key Graphic – Genes and Molecules Lead the Growth: Clinical Laboratory Services
Market by Test Type, 2026 vs 2031
Figure 2 Global Market Pareto Chart
Figure 3 Global Market by Test Type - Base vs. Final
Figure 4 Global Market by Test Type Base Year
Figure 5 Global Market by Test Type End Year
Figure 6 Test Type Share by Year
Figure 7 Test Type Segments Growth
Figure 8 Global Market by Laboratory Type - Base vs. Final
Figure 9 Global Market by Laboratory Type Base Year
Figure 10 Global Market by Laboratory Type End Year
Figure 11 Laboratory Type Share by Year
Figure 12 Laboratory Type Segments Growth
Figure 13 Global Market by Cost Component - Base vs. Final
Figure 14 Global Market by Cost Component Base Year
Figure 15 Global Market by Cost Component End Year
Figure 16 Cost Component Share by Year
Figure 17 Cost Component Segments Growth
Figure 18 Global Market by Payer - Base vs. Final
Figure 19 Global Market by Payer Base Year
Figure 20 Global Market by Payer End Year
Figure 21 Payer Share by Year
Figure 22 Payer Segments Growth
Figure 23 Global Market by Clinical Area - Base vs. Final
Figure 24 Global Market by Clinical Area Base Year
Figure 25 Global Market by Clinical Area End Year
Figure 26 Clinical Area Share by Year
Figure 27 Clinical Area Segments Growth
Figure 28 Clinical Chemistry & Immunoassay Growth
Figure 29 Haematology & Coagulation Growth
Figure 30 Microbiology & Infectious Disease Growth
Figure 31 Molecular Diagnostics Growth
Figure 32 Anatomic Pathology & Cytology Growth
Figure 33 Genetic & Genomic Testing Growth
Figure 34 Esoteric & Other Specialty Growth
Figure 35 Hospital Inpatient Growth
Figure 36 Hospital Outpatient Growth
Figure 37 Independent & Reference Labs Growth
Figure 38 Physician Office Labs Growth
Figure 39 Public Health & Other Growth
Figure 40 Instruments Growth
Figure 41 Reagents & Consumables Growth
Figure 42 Labour Growth
Figure 43 Overhead & Other Growth
Figure 44 Public Insurance Growth
Figure 45 Private Insurance Growth
Figure 46 Out-of-Pocket & Other Growth
Figure 47 Chronic & Metabolic Disease Growth
Figure 48 Infectious Disease Growth
Figure 49 Oncology Growth
Figure 50 Women's & Reproductive Health Growth
Figure 51 Wellness, Preventive & Other Growth

Clinical Laboratory Services Markets: Market Forecast, Competitive Landscape, Consolidation and Strategy, 2027-2031

Description

Table of Contents

List of Tables

Report Overview:

Table of Contents

List of Tables

List of Figures

1. Executive Summary

2. Research Methodology & Scope

3. Introduction to Clinical Laboratory Services

4. The Global Market for Clinical Laboratory Services

5. Test Menu, Volume & Utilisation Trends

6. Hospital Laboratories & Outreach

7. Technology, Automation & AI

8. Business Models & Consumer Testing

9. Regulatory & Reimbursement Landscape

10. Pricing, Costs & Workforce

11. China and Emerging Markets Laboratory Ecosystem

12. Deal-Making & M&A Analysis

13. Recent Developments

14. Laboratory Operations & Supply Chain

15. Competitive Landscape

16. SWOT, Porter's Five Forces & Investment Risk Analysis

17. Strategic Recommendations

18. Market Forecast by Test Type, 2026–2031

19. Market Forecast by Laboratory Type, 2026–2031

20. Market Forecast by Cost Component, 2026–2031

21. Market Forecast by Payer, 2026–2031

22. Market Forecast by Clinical Area, 2026–2031

23. Company Profiles

24. Appendix

List of Tables

List of Figures